Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
MIRA Pharmaceuticals, Inc. ( (MIRA) ) has shared an announcement.
On April 30, 2025, MIRA Pharmaceuticals, Inc. announced its acquisition of SKNY Pharmaceuticals, Inc., a biotechnology company specializing in obesity and nicotine dependence therapies. This strategic move, valued at over $60 million, aims to enhance MIRA’s market position by integrating complementary assets and expanding its pipeline, ultimately strengthening shareholder value.
More about MIRA Pharmaceuticals, Inc.
MIRA Pharmaceuticals, Inc. operates in the biotechnology industry, focusing on developing therapies for various health conditions.
Average Trading Volume: 1,170,223
Technical Sentiment Signal: Hold
See more data about MIRA stock on TipRanks’ Stock Analysis page.